Transmedics Group Inc (NASDAQ: TMDX) is 13.94% higher on its value in year-to-date trading and has touched a low of $36.42 and a high of $99.63 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The TMDX stock was last observed hovering at around $85.04 in the last trading session, with the day’s gains setting it 4.89%.
Currently trading at $89.93, the stock is 17.39% and 9.12% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.03 million and changing 5.75% at the moment leaves the stock 24.85% off its SMA200. TMDX registered 24.01% gain for a year compared to 6-month gain of 76.20%. The firm has a 50-day simple moving average (SMA 50) of $12.69 and a 200-day simple moving average (SMA200) of -$397.92.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 3.67% loss in the last 1 month and extending the period to 3 months gives it a 21.71%, and is 22.47% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 9.36% over the week and 5.94% over the month.
Transmedics Group Inc (TMDX) has around 584 employees, a market worth around $2.94B and $241.62M in sales. Fwd P/E is 156.66. Profit margin for the company is -10.36%. Distance from 52-week low is 146.92% and -9.74% from its 52-week high. The company has generated returns on investments over the last 12 months (-3.84%).
Transmedics Group Inc quarterly earnings per share for the current quarter are estimated at -$0.05 with sales reaching $83.78M over the same period.The EPS is expected to grow by 95.31% this year, but quarterly earnings will post 51.90% year-over-year. Quarterly sales are estimated to grow 101.60% in year-over-year returns.
Transmedics Group Inc (TMDX) Top Institutional Holders
351 institutions hold shares in Transmedics Group Inc (TMDX), with institutional investors hold 116.08% of the company’s shares. The shares outstanding are 32.67M, and float is at 31.48M with Short Float at 17.18%. Institutions hold 111.86% of the Float.
The top institutional shareholder in the company is FMR, LLC with over 3.31 million shares valued at $277.78 million. The investor’s holdings represent 10.15% of the TMDX Shares outstanding. As of Jun 29, 2023, the second largest holder is Blackrock Inc. with 2.31 million shares valued at $193.94 million to account for 7.08% of the shares outstanding. The other top investors are Lord, Abbett & Co. LLC which holds 1.87 million shares representing 5.74% and valued at over $157.02 million, while Vanguard Group Inc holds 5.47% of the shares totaling 1.78 million with a market value of $149.87 million.
Transmedics Group Inc (TMDX) Insider Activity
The most recent transaction is an insider sale by Khayal Tamer I,the company’sChief Commercial Officer. SEC filings show that Khayal Tamer I sold 4,947 shares of the company’s common stock on Apr 04 ’24 at a price of $80.36 per share for a total of $0.4 million. Following the sale, the insider now owns 25185.0 shares.
Transmedics Group Inc disclosed in a document filed with the SEC on Apr 03 ’24 that Khayal Tamer I (Chief Commercial Officer) sold a total of 5,053 shares of the company’s common stock. The trade occurred on Apr 03 ’24 and was made at $80.06 per share for $0.4 million. Following the transaction, the insider now directly holds 25185.0 shares of the TMDX stock.
Still, SEC filings show that on Apr 01 ’24, Gordon Stephen (Chief Financial Officer) disposed off 15,000 shares at an average price of $74.01 for $1.11 million. The insider now directly holds 23,299 shares of Transmedics Group Inc (TMDX).
